We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+2.09%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$6.23B
AUM Growth
-$694M
Cap. Flow
-$755M
Cap. Flow %
-12.12%
Top 10 Hldgs %
36.61%
Holding
115
New
19
Increased
25
Reduced
18
Closed
31

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 19.07%
2 Healthcare 13.74%
3 Communication Services 12.07%
4 Technology 10.64%
5 Consumer Staples 9.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRW
51
DELISTED
TRW AUTOMOTIVE HOLDINGS CORP
TRW
$25.3M 0.41%
+250,000
New +$25M
AXLL
52
DELISTED
AXIALL CORP COM STK (DE)
AXLL
$22.9M 0.37%
640,000
+23,000
+4% +$973K
ANAC
53
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$22.9M 0.37%
935,000
+501,186
+116% +$10.2M
TPH
54
DELISTED
Tri Pointe Homes
TPH
$22M 0.35%
1,701,861
+1,541,861
+964% +$21.9M
RCPT
55
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
$21.7M 0.35%
350,000
+60,000
+21% +$2.87M
RDUS
56
DELISTED
Radius Health, Inc.
RDUS
$19.9M 0.32%
949,500
-350,500
-27% -$4.74M
GWPH
57
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$19.7M 0.32%
244,000
-108,500
-31% -$9.6M
SLXP
58
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$18.7M 0.3%
+120,000
New +$17.4M
OIS icon
59
Oil States International
OIS
$522M
$16.3M 0.26%
262,952
+211,902
+415% +$13.3M
SFLY
60
DELISTED
Shutterfly, Inc.
SFLY
$14.9M 0.24%
+305,000
New +$14.9M
LPG icon
61
Dorian LPG
LPG
$2.19B
$13.1M 0.21%
735,529
-1,029,520
-58% -$20.9M
CNL
62
DELISTED
CLECO CRP (HOLDING CO)
CNL
$12M 0.19%
250,000
+211,106
+543% +$11.7M
OREX
63
DELISTED
Orexigen Therapeutics, Inc.
OREX
$11.4M 0.18%
268,430
CLVS
64
DELISTED
Clovis Oncology, Inc.
CLVS
$10.2M 0.16%
225,000
CBL
65
DELISTED
CBL& Associates Properties, Inc.
CBL
$10M 0.16%
560,000
OVTI
66
DELISTED
OMNIVISION TECHNOLOGIES INC
OVTI
$9.92M 0.16%
+375,000
New +$9.39M
FDO
67
DELISTED
FAMILY DOLLAR STORES
FDO
$9.65M 0.15%
+125,000
New +$9.21M
PWRD
68
DELISTED
PERFECT WORLD CO LTD SPONSORED ADR REPSTG CL B (CAYMAN ISL)
PWRD
$9.4M 0.15%
477,500
BYI
69
DELISTED
BALLY TECHNOLOGIES, INC.
BYI
$9.31M 0.15%
+115,358
New +$8.4M
PCO
70
DELISTED
Pendrell Corporation - Class A
PCO
$7.66M 0.12%
5,718
+11
+0.2% +$17K
RPRX
71
DELISTED
Repros Therapeutics Inc.
RPRX
$6.93M 0.11%
700,000
HELI
72
DELISTED
CHC GROUP LTD SHS NEW (CYM)
HELI
$6.6M 0.11%
39,290
-21,543
-35% -$4.45M
KMI.WS
73
DELISTED
Kinder Morgan Inc
KMI.WS
$3.64M 0.06%
+1,000,000
New +$3.37M
EIGR
74
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$2.09M 0.03%
444
KIN
75
DELISTED
Kindred Biosciences, Inc.
KIN
$1.62M 0.03%
175,000

Similar funds

Thomas Steyer's Q3 2014 Portfolio in Review

As of Q3 2014, Thomas Steyer held 115 positions worth $6.23B, down 10% from $6.93B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Thomas Steyer withdrew a net $755M in Q3 2014, closing 31 positions and reducing 18 holdings. Its most notable exit was FOREST LABORATORIES INC, an estimated $792M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 12% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Thomas Steyer opened a new position in Time Warner Inc worth $178M.

  • Thomas Steyer's largest Q3 2014 buy was Time Warner Inc: 2,365,000 shares worth $178M.
  • Thomas Steyer added most to DIRECTV COM STK (DE) in Q3 2014, an estimated $233M increase.
  • Thomas Steyer's biggest Q3 2014 reduction was American Tower, cutting an estimated $99M.
  • Thomas Steyer fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $792M.
  • Thomas Steyer's ten largest holdings make up 37% of its $6.23B portfolio in Q3 2014.
  • Thomas Steyer opened 19 new positions and closed 31 in Q3 2014.
  • Thomas Steyer's portfolio value fell 10% quarter-over-quarter to $6.23B.

Based on Farallon Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.